Question 1

How many clinical trials has Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins sponsored?

Accepted Answer

ClinicalMetric currently tracks 7 clinical trials sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, of which 7 are actively recruiting participants. These trials cover conditions including Prostate Cancer, Prostate Cancer Metastatic, Metastatic Castration-resistant Prostate Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

Question 2

What therapeutic areas does Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins research focus on?

Accepted Answer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Prostate Cancer, Prostate Cancer Metastatic, Metastatic Castration-resistant Prostate Cancer, Hematologic Malignancy.

The trial portfolio spans Phase 2, EARLY_Phase 1, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Question 3

How do I participate in a Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins clinical trial?

Accepted Answer

To participate in a Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins trials with current recruitment status updated daily.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Frequently Asked Questions — Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Clinical Trials by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer

The COSMYC Trial (COmbined Suppression of MYC)

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer

Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma

Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT